Clinical Trial Update: Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease [Phase 1]

View source ↗

Summary

A Phase 1 single- and multiple-ascending dose study in healthy volunteers and participants with an autoimmune disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Disease

Snippet

Sponsor: Almirall, S.A. | Conditions: Healthy Volunteers, Autoimmune Disease | Phase 1 | Status: COMPLETED